Acumen Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 23-10-2024
- Paid Up Capital ₹ 0.20 M
as on 23-10-2024
- Company Age 20 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 28.77 M
as on 23-10-2024
- Revenue 39.15%
(FY 2023)
- Profit 118.34%
(FY 2023)
- Ebitda 746.09%
(FY 2023)
- Net Worth 87.92%
(FY 2023)
- Total Assets -13.88%
(FY 2023)
About Acumen Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.20 M.
The company currently has active open charges totaling ₹2.88 Cr.
Nagaraju Sundaram and Nagaraju Vijayal serve as directors at the Company.
- CIN/LLPIN
U24231TN2004PTC053713
- Company No.
053713
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Jul 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Madurai, Tamil Nadu, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Acumen Pharmaceuticals Private Limited offer?
Acumen Pharmaceuticals Private Limited offers a wide range of products and services, including Pharmaceutical Machines, Capsule Filling Machines, Ointment Manufacturing Plant, Tablet Making Machines, Waterproof Paint, Waterproof Coatings.
Who are the key members and board of directors at Acumen Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nagaraju Sundaram  | Managing Director | 13-Jul-2004 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Nagaraju Vijayal | Director | 13-Jul-2004 | Current |
Financial Performance and Corporate Structure Insights of Acumen Pharmaceuticals.
Acumen Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 39.15% increase. The company also saw a substantial improvement in profitability, with a 118.34% increase in profit. The company's net worth Soared by an impressive increase of 87.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Acumen Pharmaceuticals?
In 2023, Acumen Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 29 Jan 2024 | ₹1.25 Cr | Open |
Indian Bank Creation Date: 27 Jan 2021 | ₹1.00 M | Open |
Others Creation Date: 31 May 2017 | ₹0.84 M | Open |
How Many Employees Work at Acumen Pharmaceuticals?
Acumen Pharmaceuticals has a workforce of 36 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Acumen Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Acumen Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
